A newly launched clinical study combining e-OPRA™, targeted muscle reinnervation and advanced signal decoding through implanted sensors is now getting underway at Shirley Ryan AbilityLab, the leading rehabilitation hospital in the US. The program is supported by a five-year clinical research grant of USD 8.7 million to Shirley Ryan AbilityLab from the National Institutes of Health (NIH). Through these research and development efforts, Integrum has established a unique position at the intersection of neural interfaces, osseointegration, and intelligent bionics.
News Published
Shirley Ryan AbilityLab runs first e-OPRA study in the US
Shirley Ryan AbilityLab launches the first US patient study to combine Integrum's e-OPRA™ with advanced signal decoding.
More news
Receives SEK 2.6 million refund on U.S. customs duties
Following an administrative review, Integrum has received an initial refund of SEK 2.6 million in overpaid...
Publicerad: 16 June, 2026
Afyri acclerates the development within bionics
The subsidiary Afyri will unlock the potential within e-OPRA and create an AI based platform for the...
Publicerad: 9 June, 2026
Watch Integrum's Q4 presentation
On Thursday June 4th 2026, CEO Martin Hillsten presented the report together with CFO Louise Wåhlin....
Publicerad: 4 June, 2026
Publicerad: 4 June, 2026
Integrum's Q4 report
Read Integrum’s interim report for the fourth quarter of the company’s financial year.
Publicerad: 4 June, 2026